Arbor
Arbor Biotechnologies is seeking a Director, Analytical Development to lead phase-appropriate analytical strategy, method development, and control strategy for AAV-based gene editing programs. This role involves building and guiding analytical development capabilities to support progression from early development through clinical manufacturing and regulatory submissions. The position requires technical and people leadership to partner with cross-functional teams and ensure robust analytical methods and high-quality data.
Headquarters
Uniondale, New York, United States
Company Size
501-1000 employees
Founded
1993
Arbor Realty Trust is a national direct lender that provides debt capital for the multifamily and commercial real estate industries. The firm originates and acquires mortgage loans and structured financing solutions—including agency, bridge, and other capital products—to support property owners and operators. Arbor positions itself as a capital partner for real estate investors, emphasizing tailored lending, active portfolio management, and access to institutional funding sources.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Arbor.
9% above the average for this role
Advisor, Analytical Development - Gene Therapy
Eli Lilly and Company
Associate Director/Director of CMC Analytical Development
Syncromune®
Associate Director, Analytical Quality by Design and Platform Analytical Method Life Cycle
BioLife Plasma Services
Analytical Scientist
Lexeo Therapeutics
Director, Analytical Chemistry – Genetic Medicines; Analytical Development - BR&D
Eli Lilly and Company
Principal Scientist, Pharmaceutical Analytical Sciences
Merck & Co., Inc.